the vaccine – Page 104 – Communicable Diseases Research

Drug-Induced Liver Injury After COVID-19 Vaccine

Gastroenterology

Published on 2021-07-192022-10-31
Journal: Cureus [Category] COVID-19,

Knowledge, Attitude, and Practices Toward SARS-COV-2 Infection in the United Arab Emirates Population: An Online Community-Based Cross-Sectional Survey

Public Health

Published on 2021-07-192022-10-31
Journal: Frontiers in Public Health [Category] COVID-19, MERS, SARS,

[키워드] addition age analyzed Attitude Care Contact coughing COVID-19 COVID-19 vaccine cross-sectional demographics Depression female FIVE frequencies Health healthcare providers Infection information knowledge measure men mental health Older age P-value pandemic participant Participants Patient Perceived risk PHQ-2 Population positive attitude Practice practices Prevent preventive measures questionnaire regression analysis reported Result risk SARS-COV-2 infection Self-isolation shown significantly significantly higher social media survey the vaccine United Arab Emirate Vaccine wearing masks with COVID-19
[DOI] 10.3389/fpubh.2021.687628 PMC 바로가기 [Article Type] Public Health

COVID-19 vaccinations are associated with reduced fatality rates: Evidence from cross-county quasi-experiments

Research Theme 1: COVID-19 Pandemic

Published on 2021-07-172022-10-31
Journal: Journal of Global Health [Category] COVID-19, MERS,

[키워드] 95% confidence interval acute respiratory syndrome association benefit CFR Characteristics Continuous coronavirus country Coverage COVID-19 COVID-19 case COVID-19 vaccination COVID-19 vaccine Critical death defined demonstrated dose-dependent manner effective Efficacy evaluated Evidence fatality Government Health increase in Longitudinal data nonpharmaceutical intervention outcomes Oxford random effect Randomized controlled trials reduced reduction in reductions in response Result retrieved scientist the vaccine total population Transport vaccination Vaccine vaccine dose variable was measured
[DOI] 10.7189/jogh.11.05019 PMC 바로가기 [Article Type] Research Theme 1: COVID-19 Pandemic

Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey

비활성화된 전체 비리온 SARS-CoV-2 백신(CoronaVac)의 효능 및 안전성: 터키에서 이중 맹검, 무작위, 위약 대조, 3상 시험의 중간 결과

Clinical Trial

Published on 2021-07-172022-09-12
Journal: Lancet (London, England) [Category] Fulltext, SARS, 임상, 진단,

[키워드] 1:1 95% CI adverse event adverse events antibody test result bleeding disorders blood product clinical trial Cohort component CoronaVac COVID-19 criteria dose double-blind Efficacy Efficacy and safety enrolled exclusion fatality fatigue follow-up period Frequency health-care humoral hydroxide Immunoglobulin immunosuppressive inactivated individual intention-to-treat intention-to-treat population intramuscularly IQR Local median Negative PCR nine Older outcome Pain participant PCR-confirmed per 1000 person-years per protocol Phase 3 phase 3 trial Placebo placebo-controlled protocol provided randomised Randomly recruited Registered reported safety analysis safety profile SARS-CoV-2 screened second dose shown Steroids symptomatic the placebo group the vaccine therapy Tolerability trials Turkey Vaccine virion virus Volunteer whole-virion SARS-CoV-2 vaccine yielding
[DOI] 10.1016/S0140-6736(21)01429-X PMC 바로가기 [Article Type] Clinical Trial

Young Adults’ Intentions and Rationales for COVID-19 Vaccination Participation: Evidence from a Student Survey in Ho Chi Minh City, Vietnam

Article

Published on 2021-07-162022-10-28
Journal: Vaccines [Category] COVID-19,

COVID-19 Vaccine Safety in Cancer Patients: A Single Centre Experience

Article

Published on 2021-07-162022-10-31
Journal: Cancers [Category] COVID-19,

The Long and Winding Road: Uptake, Acceptability, and Potential Influencing Factors of COVID-19 Vaccination in Austria

Article

Published on 2021-07-152022-10-28
Journal: Vaccines [Category] COVID-19,

COVID-19: Perceived Infection Risk and Barriers to Uptake of Pfizer-BioNTech and Moderna Vaccines Among Community Healthcare Workers

Article

Published on 2021-07-152022-10-30
Journal: Journal of racial and ethnic health disparities [Category] COVID-19,

Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2

인터페론-무기 RBD 이량 체는 SARS-COV-2에 대한 멸균 면역을위한 RBD의 면역 원성을 향상시킨다.

Clinical Trial

Published on 2021-07-152022-08-13
Journal: Cell Research [Category] Fulltext, SARS, 비임상, 임상, 진단, 치료제,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus adjuvant Adults antigen processing antiviral immune responses appear Biological techniques breath caused Complete coronavirus COVID-19 dimerized DLNs draining lymph node effort elicit ENhance healthy High-dose human I-P-R-F vaccine I-P-R-F I-R-F immune responses Immunity Immunoglobulin induce initiated Innate immunity interferon long-lasting long-lasting neutralizing antibodies long-lasting neutralizing antibody low dose Lower respiratory tract lymph nodes NAbs overcome placebo-controlled protective immunity provide Randomized RBD RBD dimer Receptor-binding domain respiratory rhesus macaques Safe SARS-CoV-2 severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 T cell T cell response the receptor-binding domain the vaccine Trial Trigger upper and lower respiratory tracts V-01 vaccination Vaccine vaccine candidate
[DOI] 10.1038/s41422-021-00531-8 PMC 바로가기 [Article Type] Clinical Trial

Black and Latinx Community Perspectives on COVID-19 Mitigation Behaviors, Testing, and Vaccines

Research

Published on 2021-07-152022-10-29
Journal: JAMA Network Open [Category] COVID-19, SARS,